Thousands with IBD enrolled in massive real-world treatment tracker
NCT ID NCT03162549
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study is a large registry that follows over 2,200 adults with inflammatory bowel disease (IBD) across North America. It does not test new treatments but instead observes how approved therapies work in everyday practice, including their effectiveness, safety, and how the disease progresses over time. The goal is to better understand IBD and improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.